The accreditors of this session require that you periodically check in to verify that you are still attentive.
Please click the button below to indicate that you are.
Requirements for Successful Completion: Complete the learning activity in its entirety and complete the online CNE evaluation.
Faculty, Planners and Authors Conflict of Interest Disclosure: Planning Committee: Kristin Larson – Consultant, Nephrology Clinical Solutions; Employee, Affymax; Other financial support, Kristin M. Larson, RN, MSN, LLC; Sandy Bodin – Employee, Affymax; Dawn Koonkongsatian – Employee, Fresenius Medical Care; Elizabeth St. John - Employee, Fresenius Medical Care
Presenter(s) have no disclosures to declare.
Commercial Support and Sponsorship: No commercial support or sponsorship declared.
Non-Endorsement of Products: Accreditation of activities for contact hours does not imply approval or endorsement of any product, advertising, or educational content by ANNA or the American Nurses Credentialing Center’s Commission on Accreditation.
Accreditation Statement: American Nephrology Nurses’ Association is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
ANNA is a provider approved by the California Board of Registered Nursing, provider number CEP 00910.
Objectives: • Outline the pathophysiology of hepatorenal failure. • List pharmacologic and non-pharmacologic interventions in the care of the patient with hepatorenal failure. • Compare and contrast the acute and chronic stages of hepatorenal failure.